DAS28: Disease Activity Score in rheumatoid arthritis. http://www.das-score.nl/das28/en/. Accessed 30 Nov 2016.
Druce KL, Jones GT, Macfarlane GJ, Basu N. Patients receiving anti-TNF therapies experience clinically important improvements in RA-related fatigue: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Rheumatology. 2015;54(6):964–71.
Article
PubMed
Google Scholar
McWilliams DF, Zhang W, Mansell JS, Kiely PD, Young A, Walsh DA. Predictors of change in bodily pain in early rheumatoid arthritis: an inception cohort study. Arthritis Care Res. 2012;64(10):1505–13.
Article
Google Scholar
Leeb BF, Haindl PM, Maktari A, Nothnagl T, Rintelen B. Disease Activity Score-28 values differ considerably depending on patient’s pain perception and sex. J Rheumatol. 2007;34(12):2382–7.
CAS
PubMed
Google Scholar
Ferguson E. Personality is of central concern to understand health: towards a theoretical model for health psychology. Health Psychol Rev. 2013;7 Suppl 1:S32–70.
Article
PubMed
PubMed Central
Google Scholar
Pollard LC, Ibrahim F, Choy EH, Scott DL. Pain thresholds in rheumatoid arthritis: the effect of tender point counts and disease duration. J Rheumatol. 2012;39(1):28–31.
Article
PubMed
Google Scholar
Pollard LC, Kingsley GH, Choy EH, Scott DL. Fibromyalgic rheumatoid arthritis and disease assessment. Rheumatology (Oxford). 2010;49(5):924–8.
Article
Google Scholar
Joharatnam N, McWilliams DF, Wilson D, Wheeler M, Pande I, Walsh DA. A cross sectional study of pain sensitivity, disease activity assessment, mental health and fibromyalgia status in rheumatoid arthritis. Arthritis Res Ther. 2015;17:11.
Article
PubMed
PubMed Central
Google Scholar
Druce KL, Jones GT, Macfarlane GJ, Basu N. Determining pathways to improvements in fatigue in rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Arthritis Rheumatol. 2015;67(9):2303–10.
Article
CAS
PubMed
Google Scholar
Wolfe F, Hauser W, Hassett AL, Katz RS, Walitt BT. The development of fibromyalgia - I: examination of rates and predictors in patients with rheumatoid arthritis (RA). Pain. 2011;152(2):291–9.
Article
PubMed
Google Scholar
Wolfe F, Cathey MA, Kleinheksel SM. Fibrositis (fibromyalgia) in rheumatoid arthritis. J Rheumatol. 1984;11(6):814–8.
CAS
PubMed
Google Scholar
Wolfe F, Cathey MA, Kleinheksel SM, Amos SP, Hoffman RG, Young DY, et al. Psychological status in primary fibrositis and fibrositis associated with rheumatoid arthritis. J Rheumatol. 1984;11(4):500–6.
CAS
PubMed
Google Scholar
Leeb BF, Andel I, Sautner J, Nothnagl T, Rintelen B. The DAS28 in rheumatoid arthritis and fibromyalgia patients. Rheumatology (Oxford). 2004;43(12):1504–7.
Article
CAS
Google Scholar
Coury F, Rossat A, Tebib A, Letroublon MC, Gagnard A, Fantino B, et al. Rheumatoid arthritis and fibromyalgia: a frequent unrelated association complicating disease management. J Rheumatol. 2009;36(1):58–62.
PubMed
Google Scholar
Ton E, Bakker MF, Verstappen SM, Ter Borg EJ, van Albada-Kuipers IA, Schenk Y, et al. Look beyond the Disease Activity Score of 28 joints (DAS28): tender points influence the DAS28 in patients with rheumatoid arthritis. J Rheumatol. 2012;39(1):22–7.
Article
PubMed
Google Scholar
Hodeib M, Serna-Gallegos T, Tewari KS. A review of HER2-targeted therapy in breast and ovarian cancer: lessons from antiquity - CLEOPATRA and PENELOPE. Future Oncol. 2015;11(23):3113–31.
Article
CAS
PubMed
Google Scholar
Bugatti S, Manzo A, Vitolo B, Benaglio F, Binda E, Scarabelli M, et al. High expression levels of the B cell chemoattractant CXCL13 in rheumatoid synovium are a marker of severe disease. Rheumatology. 2014;53(10):1886–95.
Article
PubMed
Google Scholar
National Institute for Health and Care Excellence (NICE). Rheumatoid arthritis in adults: management. NICE Clinical Guideline CG79. London: NICE; 2009. https://www.nice.org.uk/guidance/cg79. Accessed 30 Nov 2016.
Lee YC, Frits ML, Iannaccone CK, Weinblatt ME, Shadick NA, Williams DA, et al. Subgrouping of patients with rheumatoid arthritis based on pain, fatigue, inflammation, and psychosocial factors. Arthritis Rheumatol. 2014;66(8):2006–14.
Article
PubMed
PubMed Central
Google Scholar
Lazarsfeld PF, Henry NW. Latent structure analysis. New York: Houghton-Mifflin; 1968.
Google Scholar
Norton S, Fu B, Scott DL, Deighton C, Symmons DP, Wailoo AJ, et al. Health Assessment Questionnaire disability progression in early rheumatoid arthritis: systematic review and analysis of two inception cohorts. Semin Arthritis Rheum. 2014;44(2):131–44.
Article
PubMed
PubMed Central
Google Scholar
Schumacher FR, Kraft PA. Bayesian latent class analysis for whole-genome association analyses: an illustration using the GAW15 simulated rheumatoid arthritis dense scan data. BMC Proc. 2007;1 Suppl 1:S112.
Article
PubMed
PubMed Central
Google Scholar
Dixon WG, Symmons DP, Lunt M, Watson KD, Hyrich KL, Silman AJ. Serious infection following anti-tumor necrosis factor alpha therapy in patients with rheumatoid arthritis: lessons from interpreting data from observational studies. Arthritis Rheum. 2007;56(9):2896–904.
Article
CAS
PubMed
PubMed Central
Google Scholar
Garwood W. The Early Rheumatoid Arthritis Network (ERAN). Musculoskeletal Care. 2004;2(4):240–4.
Article
PubMed
Google Scholar
Silman A, Symmons D, Scott DG, Griffiths I. British Society for Rheumatology Biologics Register. Ann Rheum Dis. 2003;62 Suppl 2:ii28–9.
PubMed
PubMed Central
Google Scholar
Dixon WG, Watson K, Lunt M, Hyrich KL, Silman AJ, Symmons DP. Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum. 2006;54(8):2368–76.
Article
CAS
PubMed
Google Scholar
Hyrich K, Symmons D, Watson K, Silman A. Baseline comorbidity levels in biologic and standard DMARD treated patients with rheumatoid arthritis: results from a national patient register. Ann Rheum Dis. 2006;65(7):895–8.
Article
CAS
PubMed
Google Scholar
Nikiphorou E, Norton S, Carpenter L, Dixey J, Walsh DA, Kiely P, et al. Secular changes in clinical features at presentation of rheumatoid arthritis: increase in comorbidity but improved inflammatory states. Arthritis Care Res (Hoboken). doi:10.1002/acr.23014.
Kiely P, Walsh D, Williams R, Young A, Early Rheumatoid Arthritis Network (ERAN). Outcome in rheumatoid arthritis patients with continued conventional therapy for moderate disease activity—the Early RA Network (ERAN). Rheumatology (Oxford). 2011;50(5):926–31.
Article
Google Scholar
Kiely P, Williams R, Walsh D, Young A, Early Rheumatoid Arthritis Network (ERAN). Contemporary patterns of care and disease activity outcome in early rheumatoid arthritis: the ERAN cohort. Rheumatology (Oxford). 2009;48(1):57–60.
Article
CAS
Google Scholar
Hyrich KL, Watson KD, Silman AJ, Symmons DP. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register. Rheumatology (Oxford). 2006;45(12):1558–65.
Article
CAS
Google Scholar
McWilliams DF, Walsh DA. Factors predicting pain and early discontinuation of tumour necrosis factor-alpha-inhibitors in people with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register. BMC Musculoskelet Disord. 2016;17:337.
Article
PubMed
PubMed Central
Google Scholar
Ware JE, Snow KK, Kosinski M. SF-36 Health Survey: manual and interpretation guide. 2nd ed. Lincoln, RI: QualityMetric; 2000.
Google Scholar
Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum. 1980;23(2):137–45.
Article
CAS
PubMed
Google Scholar
Hagenaars JA, McCutcheon AL. Applied latent class analysis. Cambridge: Cambridge University Press; 2002.
Book
Google Scholar
Nylund KL, Asparouhov T, Muthén BO. Deciding on the number of classes in latent class analysis and growth mixture modeling: a Monte Carlo Simulation study. Struct Equ Modeling. 2007;14(4):535–69.
Article
Google Scholar
Collins LM, Lanza ST. Latent class and latent translation analysis: with applications in the social, behavioral, and health sciences. Hoboken, NJ: Wiley; 2010.
Google Scholar
Druce KL, Jones GT, Macfarlane GJ, Basu N. Examining changes in central and peripheral pain as mediates of fatigue improvement: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2016;68(7):922–6.
Article
CAS
Google Scholar
de Haas WH, de Boer W, Griffioen F, Oosten-Elst P. Rheumatoid arthritis, typus robustus. Ann Rheum Dis. 1973;32(1):91–2.
Article
PubMed
PubMed Central
Google Scholar
Azaïs J, Barnetche T, Vergne-Salle P, Bonnet C, Duauret-Lombard C, Treves R, et al. Clinical efficacy rate of the non-specific effect (the placebo effect) in the tumour necrosis factor inhibitors for rheumatoid arthritis treatment after methotrexate failure: meta-analysis [abstract]. Arthritis Rheum. 2013;65 Suppl 10:472.
Google Scholar
Druce KL, Jones GT, Macfarlane GJ, Verstappen SM, Basu N. The longitudinal course of fatigue in rheumatoid arthritis: results from the Norfolk Arthritis Register. J Rheumatol. 2015;42(11):2059–65.
Article
CAS
PubMed
Google Scholar
Lee YC, Massarotti E, Edwards RR, Lu B, Liu C, Lo Y, et al. Effect of milnacipran on pain in patients with rheumatoid arthritis with widespread pain: a randomized blinded crossover trial. J Rheumatol. 2016;43(1):38–45.
Article
CAS
PubMed
Google Scholar